Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Fox BM"" wg kryterium: Autor


Tytuł:
Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: Randomized, placebo-controlled, double-blind phase I/Ib studies in healthy subjects and patients.
Autorzy:
Vissers MFJM; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Center, Leiden, The Netherlands.
Heuberger JAAC; Centre for Human Drug Research, Leiden, The Netherlands.
Groeneveld GJ; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Center, Leiden, The Netherlands.
Oude Nijhuis J; Department of Neurology and Alzheimer Center, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
De Deyn PP; Department of Neurology and Alzheimer Center, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Laboratory of Neurochemistry and Behavior, Department of Biomedical Sciences and Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
Hadi S; PRA Health Sciences, Groningen, The Netherlands.
Harris J; Denali Therapeutics Inc., South San Francisco, California, USA.
Tsai RM; Denali Therapeutics Inc., South San Francisco, California, USA.
Cruz-Herranz A; Denali Therapeutics Inc., South San Francisco, California, USA.
Huang F; Denali Therapeutics Inc., South San Francisco, California, USA.
Tong V; Denali Therapeutics Inc., South San Francisco, California, USA.
Erickson R; Denali Therapeutics Inc., South San Francisco, California, USA.
Zhu Y; Denali Therapeutics Inc., South San Francisco, California, USA.
Scearce-Levie K; Denali Therapeutics Inc., South San Francisco, California, USA.
Hsiao-Nakamoto J; Denali Therapeutics Inc., South San Francisco, California, USA.
Tang X; Denali Therapeutics Inc., South San Francisco, California, USA.
Chang M; Denali Therapeutics Inc., South San Francisco, California, USA.
Fox BM; Denali Therapeutics Inc., South San Francisco, California, USA.
Estrada AA; Denali Therapeutics Inc., South San Francisco, California, USA.
Pomponio RJ; Sanofi Genzyme, Cambridge, Massachusetts, USA.
Alonso-Alonso M; Sanofi Genzyme, Cambridge, Massachusetts, USA.
Zilberstein M; Sanofi Genzyme, Cambridge, Massachusetts, USA.
Atassi N; Sanofi Genzyme, Cambridge, Massachusetts, USA.
Troyer MD; Denali Therapeutics Inc., South San Francisco, California, USA.
Ho C; Denali Therapeutics Inc., South San Francisco, California, USA.
Pokaż więcej
Źródło:
Clinical and translational science [Clin Transl Sci] 2022 Aug; Vol. 15 (8), pp. 2010-2023. Date of Electronic Publication: 2022 Jun 01.
Typ publikacji:
Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Alzheimer Disease*/drug therapy
Amyotrophic Lateral Sclerosis*/drug therapy
Receptor-Interacting Protein Serine-Threonine Kinases*/antagonists & inhibitors
Double-Blind Method ; Healthy Volunteers ; Humans ; Leukocytes, Mononuclear
Czasopismo naukowe
Tytuł:
Early life stress induces dysregulation of the heme pathway in adult mice.
Autorzy:
Pettway YD; Cardio-Renal Physiology and Medicine, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Neder TH; Cardio-Renal Physiology and Medicine, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Ho DH; Cardio-Renal Physiology and Medicine, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Fox BM; Cardio-Renal Physiology and Medicine, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Burch M; Cardio-Renal Physiology and Medicine, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Colson J; Cardio-Renal Physiology and Medicine, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Liu X; Cardio-Renal Physiology and Medicine, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Kellum CE; Cardio-Renal Physiology and Medicine, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Hyndman KA; Cardio-Renal Physiology and Medicine, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Pollock JS; Cardio-Renal Physiology and Medicine, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Pokaż więcej
Źródło:
Physiological reports [Physiol Rep] 2021 May; Vol. 9 (10), pp. e14844.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Maternal Deprivation*
Weaning*
Heme/*metabolism
Signal Transduction/*physiology
Stress, Psychological/*blood
Stress, Psychological/*psychology
Age Factors ; Animals ; Animals, Newborn ; Endothelium, Vascular/metabolism ; Female ; Male ; Mice ; Mice, Inbred C57BL ; Pregnancy
Czasopismo naukowe
Tytuł:
Intraventricular metastatic melanoma: A case report and review of the literature.
Autorzy:
Bernstock JD; Department of Neurosurgery Brigham and Women's Hospital Harvard Medical School Boston MA USA.
Chagoya G; Department of Neurosurgery The University of Alabama at Birmingham Birmingham AL USA.
Elsayed GA; Department of Neurosurgery The University of Alabama at Birmingham Birmingham AL USA.
Fox BM; Medical Scientist Training Program The University of Alabama at Birmingham Birmingham AL USA.
Mir N; Department of Internal Medicine The University of Alabama at Birmingham Birmingham AL USA.
Gupta S; Department of Neurosurgery Brigham and Women's Hospital Harvard Medical School Boston MA USA.
Chua M; Department of Neurosurgery Brigham and Women's Hospital Harvard Medical School Boston MA USA.
Atchley TJ; Department of Neurosurgery The University of Alabama at Birmingham Birmingham AL USA.
Lobbous M; Division of Neuro-Oncology Department of Neurology University of Alabama at Birmingham Birmingham AL USA.
Sotoudeh H; Department of Neuroradiology University of Alabama at Birmingham Birmingham AL USA.
Hackney J; Department of Pathology University of Alabama at Birmingham Birmingham AL USA.
Friedman GK; Division of Pediatric Hematology and Oncology Department of Pediatrics University of Alabama at Birmingham Birmingham AL USA.
Harrigan MR; Department of Neurosurgery The University of Alabama at Birmingham Birmingham AL USA.
Pokaż więcej
Źródło:
Clinical case reports [Clin Case Rep] 2020 Jul 03; Vol. 8 (9), pp. 1757-1764. Date of Electronic Publication: 2020 Jul 03 (Print Publication: 2020).
Typ publikacji:
Case Reports
Raport
Tytuł:
SUMOylation in Glioblastoma: A Novel Therapeutic Target.
Autorzy:
Fox BM; Department of Neurosurgery, University of Alabama at Birmingham, 1060 Faculty Office Tower, 510 20th Street South, Birmingham, AL 35223, USA. .; Medical Scientist Training Program, University of Alabama at Birmingham, 1825 University Boulevard, SHEL 121, Birmingham, AL 35294, USA. .
Janssen A; Department of Neurosurgery, University of Alabama at Birmingham, 1060 Faculty Office Tower, 510 20th Street South, Birmingham, AL 35223, USA. .
Estevez-Ordonez D; Department of Neurosurgery, University of Alabama at Birmingham, 1060 Faculty Office Tower, 510 20th Street South, Birmingham, AL 35223, USA. .
Gessler F; Department of Neurosurgery, University Hospital Frankfurt, Goethe-University, Schleusenweg 2-16, 60528 Frankfurt, Germany. .
Vicario N; Department of Biomedical and Biotechnological Sciences, Physiology Section, University of Catania, Via S. Sofia n. 97, Torre Biologica, 95123 Catania, Italy. .
Chagoya G; Department of Neurosurgery, University of Alabama at Birmingham, 1060 Faculty Office Tower, 510 20th Street South, Birmingham, AL 35223, USA. .
Elsayed G; Department of Neurosurgery, University of Alabama at Birmingham, 1060 Faculty Office Tower, 510 20th Street South, Birmingham, AL 35223, USA. .
Sotoudeh H; Division of Neuroradiology, Department of Radiology, University of Alabama at Birmingham, Jefferson Tower N419-619 19th Street South, Birmingham, AL 35223, USA. .
Stetler W; Department of Neurosurgery, University of Alabama at Birmingham, 1060 Faculty Office Tower, 510 20th Street South, Birmingham, AL 35223, USA. .
Friedman GK; Department of Neurosurgery, University of Alabama at Birmingham, 1060 Faculty Office Tower, 510 20th Street South, Birmingham, AL 35223, USA. .; Division of Neuroradiology, Department of Radiology, University of Alabama at Birmingham, Jefferson Tower N419-619 19th Street South, Birmingham, AL 35223, USA. .; Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of Alabama at Birmingham, Lowder 512, 1600 7th Avenue South, Birmingham, AL 35223, USA. .
Bernstock JD; Department of Neurosurgery, University of Alabama at Birmingham, 1060 Faculty Office Tower, 510 20th Street South, Birmingham, AL 35223, USA. .; Medical Scientist Training Program, University of Alabama at Birmingham, 1825 University Boulevard, SHEL 121, Birmingham, AL 35294, USA. .
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2019 Apr 15; Vol. 20 (8). Date of Electronic Publication: 2019 Apr 15.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Antineoplastic Agents/*pharmacology
Brain Neoplasms/*drug therapy
Brain Neoplasms/*metabolism
Glioblastoma/*drug therapy
Glioblastoma/*metabolism
Sumoylation/*drug effects
Animals ; Antineoplastic Agents/therapeutic use ; Brain/drug effects ; Brain/metabolism ; Brain/pathology ; Brain Neoplasms/pathology ; Glioblastoma/pathology ; Humans ; Molecular Targeted Therapy/methods ; Protein Processing, Post-Translational/drug effects ; Small Ubiquitin-Related Modifier Proteins/metabolism
Czasopismo naukowe
Tytuł:
Sex-specific alterations in NOS regulation of vascular function in aorta and mesenteric arteries from spontaneously hypertensive rats compared to Wistar Kyoto rats.
Autorzy:
Loria AS; Department of Pharmacology and Nutritional Sciences, University of Kentucky, St. Lexington, Kentucky.
Brinson KN; Department of Physiology, Georgia Regents University, Augusta, Georgia.
Fox BM; Department of Physiology, Georgia Regents University, Augusta, Georgia.
Sullivan JC; Department of Physiology, Georgia Regents University, Augusta, Georgia.
Pokaż więcej
Źródło:
Physiological reports [Physiol Rep] 2014 Aug 28; Vol. 2 (8). Date of Electronic Publication: 2014 Aug 28 (Print Publication: 2014).
Typ publikacji:
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies